The relationship between obesity and the severity of non-alcoholic fatty liver disease: systematic review and meta-analysis

@article{Lu2018TheRB,
  title={The relationship between obesity and the severity of non-alcoholic fatty liver disease: systematic review and meta-analysis},
  author={Feng-Bin Lu and En-de Hu and Lanman Xu and Lu Chen and Jin-Lu Wu and Hui Li and Da-zhi Chen and Yong-Ping Chen},
  journal={Expert Review of Gastroenterology \& Hepatology},
  year={2018},
  volume={12},
  pages={491 - 502}
}
ABSTRACT Introduction: A number of researches have explored the association between obesity and nonalcoholic fatty liver disease (NAFLD) liver function, histopathology, complications, genetic factors and prognosis, but the results were conflicting and inconclusive. Areas covered: In this meta-analysis, the liver function, histopathology, metabolic complications, patatin-like phospholipase domain-containing protein 3 (PNPLA3) genetic polymorphism and prognosis were compared between non-obese and… 
Association between obesity profile and non-alcoholic fatty liver by race/ethnicity
TLDR
Healthcare providers should pay more attention to care for those who are part of the metabolically healthy overweight or obese group especially among the Mexican-American population.
Assessment of the association between body composition and risk of non-alcoholic fatty liver
TLDR
Overall, the likelihood of NAFLD development rose significantly with increasing the amount of total fat and abdominal fat from the cut-off point level, and the total fat percent had the highest AUC to predict the risk ofNAFLD.
A review of non‐alcoholic fatty liver disease in non‐obese and lean individuals
TLDR
There is not enough evidence on the treatment of NAFLD in non‐obese patients, the standard approach is to advise altering one's lifestyle in order to diminish visceral adiposity, so dietary modification, weight loss, and increased physical activity are highly recommended.
Association between serum ferritin and non-alcoholic fatty liver disease among middle-aged and elderly Chinese with normal weight.
TLDR
SF was positively associated with the risk of NAFLD and elevated ALT among normal-weight Chinese adults and ROC analysis suggested that SF may serve as an indicator of predictingNAFLD.
Association of leukocyte telomere length with non-alcoholic fatty liver disease in patients with type 2 diabetes
TLDR
T2DM patients with NAFLD had a significantly longer leukocyte telomere length (LTL), which was especially evident in the early stage of T2DM, indicating that longer LTL may be used as a biomarker forNAFLD in T1DM patients.
The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
TLDR
A case can be made for screening of NAFLD to facilitate early diagnosis and to prevent the hepatic and extra-hepatic complications in high risk sub-populations with morbid obesity, diabetes, and other metabolic risk factors.
Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese.
Insulin resistance associates with hepatic lobular inflammation in subjects with obesity
TLDR
A major contributing histological component of NAFLD to the relation betweenNAFLD severity and IR seems to be the grade of hepatic lobular inflammation, which might be of importance in controlling obesity-related metabolic disturbances.
Health benefits of Mediterranean diet in nonalcoholic fatty liver disease
TLDR
A growing body of evidence has supported the idea that the Mediterranean diet, associated with physical activity and cognitive behavior therapy, may be the reference nutritional profile for the prevention and the treatment of NAFLD patients.
CHDH-PNPLA3 Gene–Gene Interactions Predict Insulin Resistance in Children with Obesity
TLDR
The interaction between genotypes in CHDH and PNPLA3 genes, modulated by choline and alanine aminotransferase levels, predicted insulin-resistance status in children with obesity.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 61 REFERENCES
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
TLDR
As the global epidemic of obesity fuels metabolic conditions, the clinical and economic burden of NAFLD will become enormous, and random‐effects models were used to provide point estimates of prevalence, incidence, mortality and incidence rate ratios.
Association of Nonalcoholic Fatty Liver Disease With Components of Metabolic Syndrome According to Body Mass Index in Korean Adults
TLDR
NAFLD was associated with risk for components of MetS, and the association was stronger in non-obese than in obese individuals, especially in women, Therefore, NAFLD should be considered a meaningful predictor of metabolic diseases in the non-OBese population.
Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh
TLDR
Nonobese was 25.6 % among NAFLD patients of Bangladesh, and 53.1 % of nonobeseNAFLD cases were NASH, and NASH and fibrosis were similar in the obese andnonobese patients.
Anthropometric and Clinical Factors Associated with Mortality in Subjects with Nonalcoholic Fatty Liver Disease
TLDR
Components of metabolic syndrome, and Mexican-American ethnicity are independently associated with nonalcoholic fatty liver disease and NAFLD is an independent predictors of liver-specific mortality in men and Whites.
Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011–2012
TLDR
The multivariate logistic regression analysis revealed that ≥10 kg of weight gain since the age of 20 was significantly associated with NAFLD in non-obese subjects of both genders, and eating an evening meal within 2 h before going to bed 3 days or more per week and drinking <20 g of alcohol per day were negatively associated in non theobese females.
Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
TLDR
The relative contribution of visceral and liver fat to insulin resistance is discussed, and recommendations for clinical evaluation of affected individuals is provided.
Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease in an Adult Population of Taiwan: Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese Adults
TLDR
In subjects with NAFLD, the prevalence of elevated ALT in the presence of each metabolic risk factor, such as obesity, fasting plasma glucose, total cholesterol, triglyceride, and hypertriglyceridemia, did not differ from that of subjects with normal ALT levels.
Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy
TLDR
Non-obese patients with NAFLD do not have a higher risk of steatohepatitis or advanced fibrosis, and patients with risk factors ofadvanced fibrosis such as metabolic syndrome and PNPLA3 G allele carriage should be assessed for severeNAFLD.
The Severity of Histologic Liver Lesions Is Independent of Body Mass Index in Patients With Nonalcoholic Fatty Liver Disease
TLDR
Almost 1 of 8 NAFLD patients coming to a Greek tertiary liver center has normal BMI, and on liver biopsy, normal BMI patients often have nonalcoholic steatohepatitis and histologic liver lesions of similar severity to the overweight or obese patients.
...
1
2
3
4
5
...